New House bill aims to shore up US API pro­duc­tion in re­sponse to pan­dem­ic short­ages

Amidst heavy de­mand for drugs and vac­cines through­out the world, a new House bill, dubbed the PRE­PARE ACT of 2021, would cre­ate a na­tion­al stock­pile of ac­tive phar­ma­ceu­ti­cal in­gre­di­ents and pre­vent sup­ply chain short­ages.

The bill, in­tro­duced by Reps. Abi­gail Span­berg­er (D-VA), and David McKin­ley (R-WV), would en­sure the coun­try has a stock­pile of APIs need­ed to man­u­fac­ture gener­ics for a list of es­sen­tial med­i­cines that would be de­ter­mined by a group that in­cludes the FDA com­mis­sion­er, the as­sis­tant sec­re­tary for pre­pared­ness and re­sponse and the sec­re­tary of de­fense. The FDA com­mis­sion­er has al­ready iden­ti­fied a list as of Oct. 30, which would be up­dat­ed at least once a year.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.